๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Soft Tissue Sarcoma Adult

Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma NCT07169344Phase 24 sites๐Ÿ“ Bergen๐Ÿ“ Oslo๐Ÿ“ Tromsรธ Oslo University Hospital ยท Tests: preoperative, Quality of life, Functional outcome FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma NCT04625907Phase 1, Phase 2128 sites๐Ÿ“ Brisbane๐Ÿ“ Camperdown๐Ÿ“ Clayton University of Birmingham ยท Tests: Irinotecan, Actinomycin D, Doxorubicin, Ifosfamide, Vincristine Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma NCT07725380Phase 1, Phase 24 sites๐Ÿ“ Tampa๐Ÿ“ St Louis๐Ÿ“ The Bronx H. Lee Moffitt Cancer Center and Research Institute ยท Tests: Domatinostat, Sirolimus Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administered in Adult Patients With Metastatic or Locally Advanced PDAC NCT07145450Phase 1, Phase 210 sites๐Ÿ“ Copenhagen๐Ÿ“ Berlin๐Ÿ“ Dresden Anocca AB ยท Tests: ANOC-001 (TCR-T cells targeting KRAS G12V mutation presented by specific HLA alleles), ANOC-002 (TCR-T cells targeting โ€ฆ SynKIR-310 for Relapsed/Refractory B-NHL NCT06544265Phase 15 sites๐Ÿ“ Denver๐Ÿ“ Atlanta๐Ÿ“ Fairway Verismo Therapeutics ยท Tests: SynKIR-310 Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies NCT04282044Phase 13 sites๐Ÿ“ Scottsdale๐Ÿ“ La Jolla๐Ÿ“ Stanford BioEclipse Therapeutics ยท Tests: CRX100 suspension for infusion, Fludarabine, Cyclophosphamide PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility Study NCT07874828Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Tirzepatide A Study of Propranolol to Treat Kaposi Sarcoma NCT05797662Phase 26 sites๐Ÿ“ Buenos Aires๐Ÿ“ Rio de Janeiro๐Ÿ“ Salvador AIDS Malignancy Consortium ยท Tests: Propranolol Propranolol for the Treatment of Kaposi Sarcoma in Adults NCT06445166Phase 21 site๐Ÿ“ St Louis Washington University School of Medicine ยท Tests: Propranolol Hydrochloride A Study of PHST001 in Advanced Solid Tumors NCT06840886Phase 120 sites๐Ÿ“ Beverly Hills๐Ÿ“ Los Angeles๐Ÿ“ Palo Alto Pheast Therapeutics ยท Tests: PHST001, Paclitaxel, Topotecan, Doxorubicin, FOLFIRI Genomic Profiles Analysis in Children, Adolescents and Young Adult With Sarcomas NCT04621201n/a10 sites๐Ÿ“ Torino๐Ÿ“ Bologna๐Ÿ“ Bologna Azienda Ospedaliera Ospedale Infantile Regina Margherita Saโ€ฆ ยท Tests: observation and biopsy Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene. NCT07192068Phase 24 sites๐Ÿ“ Angers๐Ÿ“ Marseille๐Ÿ“ Vandล“uvre-lรจs-Nancy UNICANCER ยท Tests: Zanidatamab Clonal Hematopoiesis Chemotherapy and Radiation Effects Study NCT07675967n/a1 site๐Ÿ“ Boston Dana-Farber Cancer Institute ยท Tests: Samples Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma NCT06796543NA3 sites๐Ÿ“ Washington D.C.๐Ÿ“ Baltimore๐Ÿ“ Minneapolis Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ยท Tests: Consolidative radiation therapy (cRT) IDOV-Immune for Advanced Solid Tumors NCT06910657Phase 15 sites๐Ÿ“ St Louis๐Ÿ“ Houston๐Ÿ“ San Antonio ViroMissile, Inc. ยท Tests: IDOV-Immune (oncolytic vaccinia virus) Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies NCT01109394n/a5 sites๐Ÿ“ Washington D.C.๐Ÿ“ Orange๐Ÿ“ Bethesda National Cancer Institute (NCI) Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01) NCT06395103Phase 1, Phase 271 sites๐Ÿ“ Los Angeles๐Ÿ“ Aurora๐Ÿ“ New Haven Merck Sharp & Dohme LLC ยท Tests: Zilovertamab vedotin Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM) NCT07139990Phase 11 site๐Ÿ“ Dallas University of Texas Southwestern Medical Center ยท Tests: Cohort A: Extensive Stage Small Cell Lung Cancer (ES-SCLC) Thoracic Tumor PULSAR (Personalized ultrahypofractionated stโ€ฆ Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells NCT07148050Phase 11 site๐Ÿ“ Seattle Seattle Children's Hospital ยท Tests: SC-CAR.GPC3xIL15.21 CAR T cells Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas NCT06156410Phase 14 sites๐Ÿ“ San Francisco๐Ÿ“ Aurora๐Ÿ“ Philadelphia Children's Hospital of Philadelphia ยท Tests: Cabozantinib Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS) NCT07297979Phase 111 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Baltimore Amgen ยท Tests: Xaluritamig Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women NCT06904365n/a1 site๐Ÿ“ St Louis Washington University School of Medicine ยท Tests: HyperSight cone beam computed tomography (CBCT) scan, ETHOS 2.0 Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma NCT06898970Phase 21 site๐Ÿ“ San Francisco Varun Monga, MBBS ยท Tests: Vusolimogene Oderparepvec (VO), Pembrolizumab Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility Study NCT07402577n/a1 site๐Ÿ“ Buffalo Roswell Park Cancer Institute ยท Tests: Non Intervention Study DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations NCT06988475Phase 2, Phase 317 sites๐Ÿ“ Belfast๐Ÿ“ Birmingham๐Ÿ“ Bristol Cancer Research UK ยท Tests: Capmatinib The Sarcoma Biology and Outcome Project NCT04758325n/a1 site๐Ÿ“ Heidelberg Prof. Dr. Richard F Schlenk A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas NCT07444619Phase 11 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Pazopanib, Trabectedin, Ipilimumab, Nivolumab Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors NCT06371768NA1 site๐Ÿ“ Durham Duke University ยท Tests: AYA Educational Information, AYA STEPS Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors NCT06132503Phase 11 site๐Ÿ“ West Valley City Lantern Pharma Inc. ยท Tests: LP-284 A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations NCT07629960Phase 1, Phase 216 sites๐Ÿ“ Sarasota๐Ÿ“ Tampa๐Ÿ“ Baton Rouge Blueprint Medicines Corporation ยท Tests: BLU-924
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy